Elucidation of Binding Determinants and Functional Consequences of Ras/Raf-Cysteine-rich Domain Interactions*
Abstract
Raf-1 is a critical downstream target of Ras and contains two distinct domains that bind Ras. The first Ras-binding site (RBS1) in Raf-1 has been shown to be essential for Ras-mediated translocation of Raf-1 to the plasma membrane, whereas the second site, in the Raf-1 cysteine-rich domain (Raf-CRD), has been implicated in regulating Raf kinase activity. While recognition elements that promote Ras·RBS1 complex formation have been characterized, relatively little is known about Ras/Raf-CRD interactions. In this study, we have characterized interactions important for Ras binding to the Raf-CRD. Reconciling conflicting reports, we found that these interactions are essentially independent of the guanine nucleotide bound state, but instead, are enhanced by post-translational modification of Ras. Specifically, our findings indicate that Ras farnesylation is sufficient for stable association of Ras with the Raf-CRD. Furthermore, we have also identified a Raf-CRD variant that is impaired specifically in its interactions with Ras. NMR data also suggests that residues proximal to this mutation site on the Raf-CRD form contacts with Ras. This Raf-CRD mutant impairs the ability of Ras to activate Raf kinase, thereby providing additional support that Ras interactions with the Raf-CRD are important for Ras-mediated activation of Raf-1.
- MEK
- mitogen-activated protein kinase/extracellular signal-regulated kinase kinase
- MAPK
- mitogen-activated protein kinase
- RBS-1
- Ras-binding site 1
- CRD
- cysteine-rich domain
- ELISA
- enzyme-linked immunosorbent assay
- DTT
- dithiothreitol
- PAGE
- polyacrylamide gel electrophoresis
- GNP-P(NH)P
- guanyl-5′-yl imidodiphosphate
- ERK
- extracellular signal-regulated kinase
- MBP
- myelin basic protein
- PS
- phosphatidylserine
- HSQC
- heteronuclear single quantum coherence
- Received January 19, 2000.
- Revision received March 22, 2000.
- The American Society for Biochemistry and Molecular Biology, Inc.











